Department of Otolaryngology - Head & Neck Surgery University of Illinois Chicago, Chicago, IL, United States of America; University of Illinois College of Medicine, Peoria, IL, United States of America.
Department of Otolaryngology - Head & Neck Surgery University of Illinois Chicago, Chicago, IL, United States of America.
Am J Otolaryngol. 2022 Mar-Apr;43(2):103302. doi: 10.1016/j.amjoto.2021.103302. Epub 2021 Dec 3.
We aim to investigate the true benefits of free individual HNC screening in a high-risk urban population as well as the associated risks.
This is a retrospective descriptive study. Free HNC screening was performed from 2014 to 2019. Participants were issued a questionnaire at the time of screening. After exemption by the Institutional Review Board, completed screening questionnaires were entered into a database and descriptive statistics were generated. The primary outcome measure for this study was the detection rate for HNC. We hypothesized that screening would be low yield based on previous studies (Gogarty et al., 2016).
This was a volunteer sample with a total of 410 participants, and the highest yield screening year was 2019 (n = 187). For all years, the cancer detection rate was 0%. In 2019, 134 (77.9%) of participants did not recognize the early symptoms of HNC, and 120 (73.2%) reported the screening program increased their awareness of the disease. 13 (7.6%) reported HPV vaccination while 126 (71.2%) were unaware that HPV has been linked with head and neck cancer.
HNC screening is an excellent opportunity for education regarding HNC risk factors. However, it is not a cost-effective use of physician time, does not increase detection rates even in high-risk segments of the general population, and is not completely without risk in the context of COVID-19. Perhaps the focus of HNC screening should shift from individualized screening to education and health promotion.
我们旨在调查在高危城市人群中进行免费个体头颈部癌症筛查的真正益处，以及相关风险。
这是一项回顾性描述性研究。从 2014 年到 2019 年，我们进行了免费的头颈部癌症筛查。参与者在筛查时会收到一份问卷。在机构审查委员会豁免后，填写完整的筛查问卷会被录入数据库，并生成描述性统计数据。本研究的主要结果测量是头颈部癌症的检出率。我们假设筛查的检出率会很低，这是基于之前的研究结果（Gogarty 等人，2016）。
这是一项志愿者样本研究，共有 410 名参与者，检出率最高的是 2019 年（n=187）。所有年份的癌症检出率均为 0%。在 2019 年，134 名（77.9%）参与者无法识别头颈部癌症的早期症状，120 名（73.2%）报告筛查项目提高了他们对头颈部癌症的认识。13 名（7.6%）报告接种了 HPV 疫苗，而 126 名（71.2%）不知道 HPV 与头颈部癌症有关。
头颈部癌症筛查是一个很好的教育机会，可以了解头颈部癌症的危险因素。然而，从医生的时间成本效益角度来看，它并不是一种有效的利用方式，即使在一般人群的高危人群中，也不会增加检出率，并且在 COVID-19 背景下，它也并非完全没有风险。或许头颈部癌症筛查的重点应该从个体筛查转移到教育和健康促进上。
